Adagio Medical Holdings Inc stock is traded at $1.75, with a volume of 27,722. It is up +5.42% in the last 24 hours and down -51.71% over the past month. Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
Previous Close:
$1.66
Open:
$1.60
24h Volume:
27,722
Relative Volume:
0.14
Market Cap:
$1.60M
Revenue:
$137.00K
Net Income/Loss:
-$24.37M
P/E Ratio:
-
EPS:
-$1.49
Net Cash Flow:
-$15.97M
1W Performance:
-9.33%
1M Performance:
-51.71%
6M Performance:
-93.09%
1Y Performance:
-92.59%
1-Day Range:
$1.60$1.87
1-Week Range:
$1.45$2.10
52-Week Range:
$1.45$50.70
Adagio Medical Holdings Inc Stock (ADGM) Company Profile
Name
Adagio Medical Holdings IncSector
HealthcareIndustry
Medical DevicesPhone
(949) 348-1188Address
26051 MERIT CIRCLE, LAGUNA HILLS, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS